India’S First Anti Diabetic Ayurvedic Drug BGR -34 Launched by CSIR [ Current News (Concise) ]
BGR-34, an anti-diabetic Ayurvedic drug has been launched by the Council for Scientific and Industrial Research (CSIR) which is designed for type 2 Diabetes mellitus. BGR-34 the anti-diabetic Ayurvedic drug has been equally developed by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP).
- BGR-34 controls blood sugar and provides prevention from the harmful things and deadliness of other drugs.
- It comprises 34 recognized active phyto-constitutes from herbal resources.
- As compared to latest DPP4 inhibitors it has been economically valued at 5 rupees per tablet globally.
About Council of Scientific and Industrial Research (CSIR)
- Council of Scientific and Industrial Research is an independent body and the largest research and development (R&D) association in India which was founded in 1942.
- It operates as an independent body recorded under the Registration of Societies Act of 1860.
- The Union Ministry of Science and Technology has mainly supported it.
- R&D of CSIR activities are: aerospace engineering, ocean sciences, structural engineering, metallurgy, life sciences, chemicals, mining, food, petroleum, leather, and environment.
About Central Institute for Medicinal and Aromatic Plants (CIMAP)
- Central Institute of Medicinal and Aromatic Plants is a research institute which is work under the Council of Scientific and Industrial Research (CSIR).
- Its headquarter is located in Lucknow.
- It is involved in the field of science and business of medicinal and aromatic plants.
- CIMAP has four research centers located in Bangalore, Hyderabad, Pantnagar and Purara.
- Published/Last Modified on: June 28, 2016